REACTIVO PARA LA DETERMINACIÓN DE PROPOXIFENO
Mexico·Clase I·III. Agentes de diagnóstico·BECKMAN COULTER
DE MÉXICO, S.A. DE
C.V.·Registered June 14, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- EMIT® II PLUS PROPOXYPHENE ASSAY
- Trade Name (English)
- EMIT® II PLUS PROPOXYPHENE ASSAY
- Analysis ID
- 0492R2022 SSA
- Registration Date
- June 14, 2022
- Name (Spanish)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for REACTIVO PARA LA DETERMINACIÓN DE PROPOXIFENO (REACTIVO PARA LA DETERMINACIÓN DE PROPOXIFENO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0492R2022 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on June 14, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.